{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:21:43Z","timestamp":1755217303252,"version":"3.43.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"DOI":"10.1007\/s10585-025-10354-1","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:40:10Z","timestamp":1749685210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MRI-guided stereotactic radiotherapy for oligometastatic peritoneal carcinomatosis: toward integrative oncologic approaches"],"prefix":"10.1007","volume":"42","author":[{"given":"Angela","family":"Romano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuditta","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Panza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Castan\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Campitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Costamagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Nardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Valerio","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Votta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"10354_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/bjs.10422","volume":"104","author":"NFM Kok","year":"2017","unstructured":"Kok NFM, de Hingh IHJT (2017) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases of colorectal origin. Br J Surg 104:313\u2013315. https:\/\/doi.org\/10.1002\/bjs.10422","journal-title":"Br J Surg"},{"key":"10354_CR2","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.3747\/co.23.2831","volume":"23","author":"J Spiliotis","year":"2016","unstructured":"Spiliotis J, Halkia E, de Bree E (2016) Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Curr Oncol 23:e266\u2013275. https:\/\/doi.org\/10.3747\/co.23.2831","journal-title":"Curr Oncol"},{"key":"10354_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cncr.23553","volume":"113","author":"A Di Giorgio","year":"2008","unstructured":"Di Giorgio A, Naticchioni E, Biacchi D et al (2008) Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 113:315\u2013325. https:\/\/doi.org\/10.1002\/cncr.23553","journal-title":"Cancer"},{"key":"10354_CR4","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ejso.2015.08.172","volume":"41","author":"YR Huo","year":"2015","unstructured":"Huo YR, Richards A, Liauw W, Morris DL (2015) Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis. Eur J Surg Oncol 41:1578\u20131589. https:\/\/doi.org\/10.1016\/j.ejso.2015.08.172","journal-title":"Eur J Surg Oncol"},{"key":"10354_CR5","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.ejso.2014.06.006","volume":"40","author":"D Elias","year":"2014","unstructured":"Elias D, Mariani A, Cloutier A-S et al (2014) Modified selection criteria for complete cytoreductive surgery plus HIPEC based on peritoneal cancer index and small bowel involvement for peritoneal carcinomatosis of colorectal origin. Eur J Surg Oncol 40:1467\u20131473. https:\/\/doi.org\/10.1016\/j.ejso.2014.06.006","journal-title":"Eur J Surg Oncol"},{"key":"10354_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1007\/s11547-021-01369-1","volume":"126","author":"R Fusco","year":"2021","unstructured":"Fusco R, Granata V, Sansone M et al (2021) Validation of the standardized index of shape tool to analyze DCE-MRI data in the assessment of neo-adjuvant therapy in locally advanced rectal cancer. Radiol Med 126:1044\u20131054. https:\/\/doi.org\/10.1007\/s11547-021-01369-1","journal-title":"Radiol Med"},{"key":"10354_CR7","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","volume":"30","author":"I van \u2019t Sant","year":"2020","unstructured":"van \u2019t Sant I, Engbersen MP, Bhairosing PA et al (2020) Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis. Eur Radiol 30:3101\u20133112. https:\/\/doi.org\/10.1007\/s00330-019-06524-x","journal-title":"Eur Radiol"},{"key":"10354_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.3748\/wjg.v18.i13.1496","volume":"18","author":"F Iacobellis","year":"2012","unstructured":"Iacobellis F, Berritto D, Somma F et al (2012) Magnetic resonance imaging: A new tool for diagnosis of acute ischemic colitis? World J Gastroenterol 18:1496\u20131501. https:\/\/doi.org\/10.3748\/wjg.v18.i13.1496","journal-title":"World J Gastroenterol"},{"key":"10354_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000454694","volume":"33","author":"B Rau","year":"2017","unstructured":"Rau B, Brandl A, Pascher A et al (2017) Oligometastatic disease in the peritoneal space with Gastrointestinal Cancer. Visc Med 33:42\u201346. https:\/\/doi.org\/10.1159\/000454694","journal-title":"Visc Med"},{"key":"10354_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359\u2013374. https:\/\/doi.org\/10.1007\/978-1-4613-1247-5_23","journal-title":"Cancer Treat Res"},{"key":"10354_CR11","first-page":"81","volume":"20","author":"J Esquivel","year":"1999","unstructured":"Esquivel J, Farinetti A, Sugarbaker PH (1999) [Elective surgery in recurrent colon cancer with peritoneal seeding: when to and when not to proceed]. G Chir 20:81\u201386","journal-title":"G Chir"},{"key":"10354_CR12","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1245\/s10434-015-4627-8","volume":"23","author":"M Faron","year":"2016","unstructured":"Faron M, Macovei R, Go\u00e9r\u00e9 D et al (2016) Linear relationship of peritoneal Cancer index and survival in patients with peritoneal metastases from colorectal Cancer. Ann Surg Oncol 23:114\u2013119. https:\/\/doi.org\/10.1245\/s10434-015-4627-8","journal-title":"Ann Surg Oncol"},{"key":"10354_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","volume":"28","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Boutitie F et al (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63\u201368. https:\/\/doi.org\/10.1200\/JCO.2009.23.9285","journal-title":"J Clin Oncol"},{"key":"10354_CR14","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.3748\/wjg.v25.i27.3484","volume":"25","author":"JM S\u00e1nchez-Hidalgo","year":"2019","unstructured":"S\u00e1nchez-Hidalgo JM, Rodr\u00edguez-Ortiz L, Arjona-S\u00e1nchez \u00c1 et al (2019) Colorectal peritoneal metastases: optimal management review. World J Gastroenterol 25:3484\u20133502. https:\/\/doi.org\/10.3748\/wjg.v25.i27.3484","journal-title":"World J Gastroenterol"},{"key":"10354_CR15","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","volume":"249","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as A highly morbid procedure? A systematic review of morbidity and mortality. Ann Surg 249:900\u2013907. https:\/\/doi.org\/10.1097\/SLA.0b013e3181a45d86","journal-title":"Ann Surg"},{"key":"10354_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejogrb.2014.05.018","volume":"179","author":"P Cascales-Campos","year":"2014","unstructured":"Cascales-Campos P, Gil J, Gil E et al (2014) Cytoreduction and HIPEC after neoadjuvant chemotherapy in stage IIIC-IV ovarian cancer. Critical analysis in elderly patients. Eur J Obstet Gynecol Reprod Biol 179:88\u201393. https:\/\/doi.org\/10.1016\/j.ejogrb.2014.05.018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10354_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ygyno.2023.04.002","volume":"173","author":"T Gauduchon","year":"2023","unstructured":"Gauduchon T, Kfoury M, Lorusso D et al (2023) PARP inhibitors (PARPi) prolongation after local therapy for oligo-metastatic progression in relapsed ovarian cancer patients. Gynecol Oncol 173:98\u2013105. https:\/\/doi.org\/10.1016\/j.ygyno.2023.04.002","journal-title":"Gynecol Oncol"},{"key":"10354_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/978-0-387-48993-3_30","volume":"134","author":"T Boterberg","year":"2007","unstructured":"Boterberg T, Duthoy W, De Neve W (2007) The role of radiotherapy in the treatment of peritoneal carcinomatosis. Cancer Treat Res 134:449\u2013457. https:\/\/doi.org\/10.1007\/978-0-387-48993-3_30","journal-title":"Cancer Treat Res"},{"key":"10354_CR19","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0360-3016(92)90777-f","volume":"22","author":"AJ Dembo","year":"1992","unstructured":"Dembo AJ (1992) Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys 22:835\u2013845. https:\/\/doi.org\/10.1016\/0360-3016(92)90777-f","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10354_CR20","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1002\/1097-0142(19941201)74:11<2979::aid-cncr2820741114>3.0.co;2-b","volume":"74","author":"BW Corn","year":"1994","unstructured":"Corn BW, Lanciano RM, Boente M et al (1994) Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure. Cancer 74:2979\u20132983. https:\/\/doi.org\/10.1002\/1097-0142(19941201)74:11%3C2979::aid-cncr2820741114%3E3.0.co;2-b","journal-title":"Cancer"},{"key":"10354_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tipsro.2020.06.001","volume":"15","author":"L Placidi","year":"2020","unstructured":"Placidi L, Romano A, Chiloiro G et al (2020) On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: clinical and dosimetric considerations. Tech Innovations Patient Support Radiation Oncol 15:15\u201321. https:\/\/doi.org\/10.1016\/j.tipsro.2020.06.001","journal-title":"Tech Innovations Patient Support Radiation Oncol"},{"key":"10354_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/acm2.13030","volume":"21","author":"L Placidi","year":"2020","unstructured":"Placidi L, Cusumano D, Boldrini L et al (2020) Quantitative analysis of MRI-guided radiotherapy treatment process time for tumor real-time gating efficiency. J Appl Clin Med Phys 21:70\u201379. https:\/\/doi.org\/10.1002\/acm2.13030","journal-title":"J Appl Clin Med Phys"},{"key":"10354_CR23","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00432-020-03480-8","volume":"147","author":"L Boldrini","year":"2021","unstructured":"Boldrini L, Romano A, Mariani S et al (2021) MRI-guided stereotactic radiation therapy for hepatocellular carcinoma: a feasible and safe innovative treatment approach. J Cancer Res Clin Oncol 147:2057\u20132068. https:\/\/doi.org\/10.1007\/s00432-020-03480-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"10354_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ctro.2019.04.007","volume":"18","author":"S Kl\u00fcter","year":"2019","unstructured":"Kl\u00fcter S (2019) Technical design and concept of a 0.35 T MR-Linac. Clin Translational Radiation Oncol 18:98\u2013101. https:\/\/doi.org\/10.1016\/j.ctro.2019.04.007","journal-title":"Clin Translational Radiation Oncol"},{"key":"10354_CR25","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.ctro.2024.100881","volume":"50","author":"S Ding","year":"2025","unstructured":"Ding S, Piao Z, Chen M et al (2025) MRI guided online adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion in patients with cervical cancer. Clin Translational Radiation Oncol 50:100881. https:\/\/doi.org\/10.1016\/j.ctro.2024.100881","journal-title":"Clin Translational Radiation Oncol"},{"key":"10354_CR26","doi-asserted-by":"publisher","first-page":"100926","DOI":"10.1016\/j.ctro.2025.100926","volume":"52","author":"A Dinesan","year":"2025","unstructured":"Dinesan A, Singh M, Mehta P et al (2025) Acute enteritis with pelvic SBRT: influence of bowel delineation methods. Clin Translational Radiation Oncol 52:100926. https:\/\/doi.org\/10.1016\/j.ctro.2025.100926","journal-title":"Clin Translational Radiation Oncol"},{"key":"10354_CR27","doi-asserted-by":"publisher","first-page":"601739","DOI":"10.3389\/fonc.2020.601739","volume":"10","author":"L Boldrini","year":"2020","unstructured":"Boldrini L, Romano A, Placidi L et al (2020) Case report: first in human online adaptive MR guided SBRT of peritoneal carcinomatosis nodules: A new therapeutic approach for the Oligo-Metastatic patient. Front Oncol 10:601739. https:\/\/doi.org\/10.3389\/fonc.2020.601739","journal-title":"Front Oncol"},{"key":"10354_CR28","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB et al (2020) Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of Cancer consensus recommendation. Lancet Oncol 21:e18\u2013e28. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1","journal-title":"Lancet Oncol"},{"key":"10354_CR29","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5301\/tj.5000623","volume":"103","author":"D Cavaliere","year":"2017","unstructured":"Cavaliere D, Cirocchi R, Coccolini F et al (2017) 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer. Tumori 103:525\u2013536. https:\/\/doi.org\/10.5301\/tj.5000623","journal-title":"Tumori"},{"key":"10354_CR30","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.ctro.2023.100615","volume":"40","author":"L Boldrini","year":"2023","unstructured":"Boldrini L, Alongi F, Romano A et al (2023) Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey. Clin Transl Radiat Oncol 40:100615. https:\/\/doi.org\/10.1016\/j.ctro.2023.100615","journal-title":"Clin Transl Radiat Oncol"},{"key":"10354_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","volume":"4","author":"SK Jabbour","year":"2014","unstructured":"Jabbour SK, Hashem SA, Bosch W et al (2014) Upper abdominal normal organ contouring guidelines and atlas: a radiation therapy oncology group consensus. Pract Radiat Oncol 4:82\u201389. https:\/\/doi.org\/10.1016\/j.prro.2013.06.004","journal-title":"Pract Radiat Oncol"},{"key":"10354_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/acm2.12697","volume":"20","author":"D Cusumano","year":"2019","unstructured":"Cusumano D, Boldrini L, Menna S et al (2019) Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer. J Appl Clin Med Phys 20:20\u201330. https:\/\/doi.org\/10.1002\/acm2.12697","journal-title":"J Appl Clin Med Phys"},{"key":"10354_CR33","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1118\/1.4953198","volume":"43","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mazur TR, Green O et al (2016) A GPU-accelerated Monte Carlo dose calculation platform and its application toward validating an MRI-guided radiation therapy beam model. Med Phys 43:4040. https:\/\/doi.org\/10.1118\/1.4953198","journal-title":"Med Phys"},{"key":"10354_CR34","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.prro.2020.07.003","volume":"11","author":"G G\u00fcng\u00f6r","year":"2021","unstructured":"G\u00fcng\u00f6r G, Serbez \u0130, Temur B et al (2021) Time analysis of online adaptive magnetic Resonance-Guided radiation therapy workflow according to anatomical sites. Pract Radiat Oncol 11:e11\u2013e21. https:\/\/doi.org\/10.1016\/j.prro.2020.07.003","journal-title":"Pract Radiat Oncol"},{"key":"10354_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/14736691221141950","volume":"22","author":"PJ Keall","year":"2022","unstructured":"Keall PJ, Glide-Hurst CK, Cao M et al (2022) ICRU REPORT 97: MRI-Guided radiation therapy using MRI-Linear accelerators. JICRU 22:1\u2013100. https:\/\/doi.org\/10.1177\/14736691221141950","journal-title":"JICRU"},{"key":"10354_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clon.2022.02.010","volume":"34","author":"P Diez","year":"2022","unstructured":"Diez P, Hanna GG, Aitken KL et al (2022) UK 2022 consensus on normal tissue Dose-Volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol (R Coll Radiol) 34:288\u2013300. https:\/\/doi.org\/10.1016\/j.clon.2022.02.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10354_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.radonc.2017.07.028","volume":"125","author":"O Bohoudi","year":"2017","unstructured":"Bohoudi O, Bruynzeel AME, Senan S et al (2017) Fast and robust online adaptive planning in stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer. Radiother Oncol 125:439\u2013444. https:\/\/doi.org\/10.1016\/j.radonc.2017.07.028","journal-title":"Radiother Oncol"},{"key":"10354_CR38","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"10354_CR39","unstructured":"National Cancer Institute (NCI) (2017) Common Terminology Criteria for Adverse Events (CTCAE)"},{"key":"10354_CR40","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M et al (2013) Peritoneal carcinomatosis. World J Gastroenterol 19:6979\u20136994. https:\/\/doi.org\/10.3748\/wjg.v19.i41.6979","journal-title":"World J Gastroenterol"},{"key":"10354_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.21037\/jgo.2017.12.04","volume":"9","author":"G Montori","year":"2018","unstructured":"Montori G, Coccolini F, Fugazzola P et al (2018) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and Gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. J Gastrointest Oncol 9:241\u2013253. https:\/\/doi.org\/10.21037\/jgo.2017.12.04","journal-title":"J Gastrointest Oncol"},{"key":"10354_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/PPO.0b013e3181a58d56","volume":"15","author":"F Mohamed","year":"2009","unstructured":"Mohamed F, Moran BJ (2009) Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J 15:196\u2013199. https:\/\/doi.org\/10.1097\/PPO.0b013e3181a58d56","journal-title":"Cancer J"},{"key":"10354_CR43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/codi.12975","volume":"17","author":"B Moran","year":"2015","unstructured":"Moran B, Cecil T, Chandrakumaran K et al (2015) The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Colorectal Dis 17:772\u2013778. https:\/\/doi.org\/10.1111\/codi.12975","journal-title":"Colorectal Dis"},{"key":"10354_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.suronc.2017.01.001","volume":"26","author":"H Aza\u00efs","year":"2017","unstructured":"Aza\u00efs H, Estevez JP, Foucher P et al (2017) Dealing with microscopic peritoneal metastases of epithelial ovarian cancer. A surgical challenge. Surg Oncol 26:46\u201352. https:\/\/doi.org\/10.1016\/j.suronc.2017.01.001","journal-title":"Surg Oncol"},{"key":"10354_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/IGC.0000000000001173","volume":"28","author":"M Rosendahl","year":"2018","unstructured":"Rosendahl M, Harter P, Bj\u00f8rn SF, H\u00f8gdall C (2018) Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian Cancer. Int J Gynecol Cancer 28:316\u2013322. https:\/\/doi.org\/10.1097\/IGC.0000000000001173","journal-title":"Int J Gynecol Cancer"},{"key":"10354_CR46","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jso.27890","volume":"130","author":"J Demuytere","year":"2024","unstructured":"Demuytere J, Ernst S, Ceelen W (2024) Pathophysiology of peritoneal metastasis. J Surg Oncol 130:1299\u20131305. https:\/\/doi.org\/10.1002\/jso.27890","journal-title":"J Surg Oncol"},{"key":"10354_CR47","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/jcm11020458","volume":"11","author":"Y Yonemura","year":"2022","unstructured":"Yonemura Y, Ishibashi H, Mizumoto A et al (2022) The development of peritoneal metastasis from gastric Cancer and rationale of treatment according to the mechanism. J Clin Med 11:458. https:\/\/doi.org\/10.3390\/jcm11020458","journal-title":"J Clin Med"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-025-10354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-025-10354-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-025-10354-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T11:03:20Z","timestamp":1754391800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-025-10354-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["10354"],"URL":"https:\/\/doi.org\/10.1007\/s10585-025-10354-1","relation":{},"ISSN":["1573-7276"],"issn-type":[{"type":"electronic","value":"1573-7276"}],"subject":[],"published":{"date-parts":[[2025,6,12]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LB had active research agreements with Roche and ViewRay Systems, Inc. and received speaker honoraria for scientific presentations and travel reimbursements. LP reports a consulting agreement and research grants with ViewRay Systems, Inc. outside the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}